Business Description
Beijing Bohui Innovation Biotechnology Group Co Ltd
NAICS : 333999
SIC : 3829
ISIN : CNE000001QR4
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 8.44 | |||||
Interest Coverage | 4.93 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year FCF Growth Rate | 19.5 | |||||
3-Year Book Growth Rate | 1.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.59 | |||||
9-Day RSI | 52.77 | |||||
14-Day RSI | 54.23 | |||||
6-1 Month Momentum % | 0.62 | |||||
12-1 Month Momentum % | -17.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.12 | |||||
Quick Ratio | 0.25 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 617.4 | |||||
Days Sales Outstanding | 18.73 | |||||
Days Payable | 185.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.46 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.25 | |||||
Operating Margin % | 12.4 | |||||
Net Margin % | -0.32 | |||||
FCF Margin % | -12.22 | |||||
ROE % | -0.23 | |||||
ROA % | -0.08 | |||||
ROIC % | 2.87 | |||||
ROC (Joel Greenblatt) % | 6.11 | |||||
ROCE % | 3.98 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 1440 | |||||
PS Ratio | 4.68 | |||||
PB Ratio | 3.37 | |||||
Price-to-Tangible-Book | 21.33 | |||||
Price-to-Operating-Cash-Flow | 63.99 | |||||
EV-to-EBIT | 47.23 | |||||
EV-to-EBITDA | 47.23 | |||||
EV-to-Revenue | 5.41 | |||||
EV-to-FCF | -44.09 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Graham-Number | 36 | |||||
Earnings Yield (Greenblatt) % | 2.12 | |||||
FCF Yield % | -2.69 | |||||
Forward Rate of Return (Yacktman) % | -20.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Beijing Bohui Innovation Biotechnology Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,005.405 | ||
EPS (TTM) (Â¥) | -0.004 | ||
Beta | 0.94 | ||
Volatility % | 41.04 | ||
14-Day RSI | 54.23 | ||
14-Day ATR (Â¥) | 0.31634 | ||
20-Day SMA (Â¥) | 5.3145 | ||
12-1 Month Momentum % | -17.65 | ||
52-Week Range (Â¥) | 3.43 - 7.17 | ||
Shares Outstanding (Mil) | 816.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Beijing Bohui Innovation Biotechnology Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Beijing Bohui Innovation Biotechnology Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Beijing Bohui Innovation Biotechnology Group Co Ltd Frequently Asked Questions
What is Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318)'s stock price today?
When is next earnings date of Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318)?
Does Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |